Hanna Przepiera-Będzak Selected Research

Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)

8/2016

Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanna Przepiera-Będzak Research Topics

Disease

5	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2021 - 01/2013
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 01/2017
3	Anterior Uveitis 01/2022 - 01/2016
3	Ankylosing Spondylitis 08/2016 - 01/2015
3	Psoriatic Arthritis 08/2016 - 01/2013
2	Atherosclerotic Plaque (Atheroma) 09/2022 - 01/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2016
2	Axial Spondyloarthritis 01/2022 - 01/2017
2	Synovitis 01/2021 - 08/2016
2	Acne Vulgaris 01/2021 - 08/2016
2	Hyperostosis 01/2021 - 08/2016
2	Osteitis 01/2021 - 08/2016
2	Arthritis (Polyarthritis) 01/2017 - 01/2013
2	Thrombosis (Thrombus) 01/2017 - 12/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017 - 01/2013
1	Inflammation (Inflammations) 11/2023
1	Raynaud Disease (Raynaud's Disease) 09/2022
1	Atherosclerosis 09/2022
1	Stroke (Strokes) 09/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2017
1	Lupus Nephritis 01/2017
1	Obesity 01/2017
1	Thromboembolism 12/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2016
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2016
1	Onycholysis 01/2016

Drug/Important Bio-Agent (IBA)

4	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
3	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2016
3	CytokinesIBA 01/2021 - 01/2013
2	AutoantibodiesIBA 11/2023 - 01/2017
2	AntibodiesIBA 09/2022 - 12/2016
2	alpha-2-HS-GlycoproteinIBA 01/2022 - 08/2016
2	Antiphospholipid AntibodiesIBA 01/2017 - 12/2016
2	Epidermal Growth Factor (EGF)IBA 03/2016 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 01/2013
1	Transferrin Receptors (Transferrin Receptor)IBA 12/2023
1	Interleukin-10 (Interleukin 10)IBA 11/2023
1	DNA (Deoxyribonucleic Acid)IBA 09/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2022
1	PhosphatidylserinesIBA 09/2022
1	phosphatidylethanolamineIBA 09/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	amsonic acid (DAS)IBA 01/2017
1	InterleukinsIBA 01/2017
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2017
1	enoxaparin sodium FDA LinkGeneric 12/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2016
1	Endothelin-1 (Endothelin 1)IBA 08/2016

Therapy/Procedure

1	Therapeutics 01/2021